These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14511953)

  • 1. DNA vaccine strategies: candidates for immune modulation and immunization regimens.
    Doria-Rose NA; Haigwood NL
    Methods; 2003 Nov; 31(3):207-16. PubMed ID: 14511953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens.
    Asbach B; Kliche A; Köstler J; Perdiguero B; Esteban M; Jacobs BL; Montefiori DC; LaBranche CC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Landucci G; Forthal DN; Seaman MS; Hawkins N; Self SG; Sato A; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Francis J; Galmin L; Ding S; Heeney JL; Pantaleo G; Wagner R
    J Virol; 2016 Apr; 90(8):4133-4149. PubMed ID: 26865719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant formulations and delivery systems for DNA vaccines.
    Sasaki S; Takeshita F; Xin KQ; Ishii N; Okuda K
    Methods; 2003 Nov; 31(3):243-54. PubMed ID: 14511957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).
    Zhang W; Ahmad G; Torben W; Siddiqui AA
    Acta Trop; 2011 May; 118(2):142-51. PubMed ID: 21334302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating specific priming of immune effector functions by DNA-based vaccination strategies.
    Reimann J; Schirmbeck R
    Dev Biol (Basel); 2000; 104():15-24. PubMed ID: 11713813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
    Meerak J; Wanichwecharungruang SP; Palaga T
    Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines.
    Weiss R; Scheiblhofer S; Freund J; Ferreira F; Livey I; Thalhamer J
    Vaccine; 2002 Aug; 20(25-26):3148-54. PubMed ID: 12163266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical DNA vaccination with DNA/Lipid based complex.
    Choi MJ; Kim JH; Maibach HI
    Curr Drug Deliv; 2006 Jan; 3(1):37-45. PubMed ID: 16472092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.
    Kwissa M; Lindblad EB; Schirmbeck R; Reimann J
    J Mol Med (Berl); 2003 Aug; 81(8):502-10. PubMed ID: 12879151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of DNA vaccines: current progress.
    Ferraro B; Morrow MP; Hutnick NA; Shin TH; Lucke CE; Weiner DB
    Clin Infect Dis; 2011 Aug; 53(3):296-302. PubMed ID: 21765081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus.
    Cai D; Song Q; Duan C; Wang S; Wang J; Zhu Y
    Vaccine; 2018 Sep; 36(37):5591-5599. PubMed ID: 30077483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunization with DNA vaccines.
    Hobson P; Barnfield C; Barnes A; Klavinskis LS
    Methods; 2003 Nov; 31(3):217-24. PubMed ID: 14511954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
    Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
    Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
    J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes.
    Chow YH; Chiang BL; Lee YL; Chi WK; Lin WC; Chen YT; Tao MH
    J Immunol; 1998 Feb; 160(3):1320-9. PubMed ID: 9570550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical vaccination of DNA antigens: topical delivery of DNA antigens.
    Choi MJ; Maibach HI
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):271-82. PubMed ID: 12907832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity.
    Ranasinghe C; Ramshaw IA
    Expert Rev Vaccines; 2009 Sep; 8(9):1171-81. PubMed ID: 19722891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.